BiotechTube

alglucosidase alfa + Placebo

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pompe Disease (Late-onset)

Conditions

Pompe Disease (Late-onset), Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease, Glycogenosis 2

Trial Timeline

Sep 1, 2005 → Sep 1, 2007

NCT ID
NCT00158600

About alglucosidase alfa + Placebo

alglucosidase alfa + Placebo is a phase 3 stage product being developed by Sanofi for Pompe Disease (Late-onset). The current trial status is completed. This product is registered under clinical trial identifier NCT00158600. Target conditions include Pompe Disease (Late-onset), Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease.

What happened to similar drugs?

10 of 16 similar drugs in Pompe Disease (Late-onset) were approved

Approved (10) Terminated (4) Active (5)
✅alglucosidase alfaSanofiApproved
✅alglucosidase alfaSanofiApproved
✅Alglucosidase alfaSanofiApproved
✅alglucosidase alfaSanofiApproved
🔄MyozymeSanofiPhase 3
✅alglucosidase alfaSanofiApproved
🔄Avalglucosidase alfa (GZ402666) + Alglucosidase alfa (GZ419829)SanofiPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00158600Phase 3Completed

Competing Products

20 competing products in Pompe Disease (Late-onset)

See all competitors
ProductCompanyStageHype Score
S-606001 + PlaceboShionogiPhase 2
42
alglucosidase alfaSanofiApproved
43
GZ402666SanofiPhase 1
29
alglucosidase alfaSanofiApproved
43
glucosidase alfaSanofiPre-clinical
26
Alglucosidase alfaSanofiApproved
35
Avalglucosidase AlfaSanofiPhase 2
35
alglucosidase alfaSanofiApproved
43
MyozymeSanofiPhase 3
40
alglucosidase alfaSanofiApproved
43
alglucosidase alfaSanofiPre-clinical
26
Avalglucosidase alfa (GZ402666) + Alglucosidase alfa (GZ419829)SanofiPhase 3
40
Myozyme® (alglucosidase alfa) + Myozyme® (alglucosidase alfa)SanofiApproved
35
ALGLUCOSIDASE ALFASanofiApproved
43
alglucosidase alfa + alglucosidase alfaSanofiApproved
35
Avalglucosidase alfa (GZ402666) + Alglucosidase alfa (GZ419829)SanofiPhase 2
39
MyozymeSanofiPhase 2
35
MyozymeSanofiPhase 2
35
recombinant human acid alpha-glucosidase (rhGAA)SanofiPhase 2
35
Alglucosidase Alfa + Methotrexate + RituximabSanofiApproved
43